Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures

Publisher Website
Google Scholar
Abstract
Toll‐like receptor (TLR)‐7 agonists represent a new group of immune response modifiers, which include imiquimod and resiquimod (R‐848). Topically applied imiquimod is used for the treatment of both external and perianal genital warts, and benign and malignant epithelial lesions. Based on the induction of interferons and other cytokines in vitro and in vivo, regression of epithelial lesions probably depends on induction of both innate and cellular immune responses. As clinical remission is not always associated with inflammation, other mechanisms may also be involved. Using two different assays for detection of apoptosis (TUNEL test and gel analysis of DNA fragmentation), we observed induction of apoptosis by imiquimod in human epithelial cell lines (HeLa S3) and keratinocytes (HaCaT, A431 cells), as well as in mouse fibroblasts (McCoy cells). These findings suggest that the mode of action of imiquimod to eliminate virus‐infected, dysplastic or neoplastic epithelial cells may also include the induction of apoptotic processes.